Medios AG
Status: Publicly traded
Direct answer
Medios AG is publicly traded on XETRA under the ticker ILM1.DE.
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition...
Can you invest in Medios AG?
Yes. Medios AG trades publicly on XETRA as ILM1.DE.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.